These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32004600)

  • 1. Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression.
    Masjedi A; Ahmadi A; Atyabi F; Farhadi S; Irandoust M; Khazaei-Poul Y; Ghasemi Chaleshtari M; Edalati Fathabad M; Baghaei M; Haghnavaz N; Baradaran B; Hojjat-Farsangi M; Ghalamfarsa G; Sabz G; Hasanzadeh S; Jadidi-Niaragh F
    Int J Biol Macromol; 2020 Apr; 149():487-500. PubMed ID: 32004600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice.
    Bastaki S; Aravindhan S; Ahmadpour Saheb N; Afsari Kashani M; Evgenievich Dorofeev A; Karoon Kiani F; Jahandideh H; Beigi Dargani F; Aksoun M; Nikkhoo A; Masjedi A; Mahmoodpoor A; Ahmadi M; Dolati S; Namvar Aghdash S; Jadidi-Niaragh F
    Life Sci; 2021 Feb; 266():118847. PubMed ID: 33309720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coinhibition of S1PR1 and GP130 by siRNA-loaded alginate-conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells.
    Rostami N; Nikkhoo A; Khazaei-Poul Y; Farhadi S; Sadat Haeri M; Moghadaszadeh Ardebili S; Aghaei Vanda N; Atyabi F; Namdar A; Baghaei M; Haghnavaz N; Kazemi T; Yousefi M; Ghalamfarsa G; Sabz G; Jadidi-Niaragh F
    J Cell Physiol; 2020 Dec; 235(12):9702-9717. PubMed ID: 32424937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression.
    Izadi S; Moslehi A; Kheiry H; Karoon Kiani F; Ahmadi A; Masjedi A; Ghani S; Rafiee B; Karpisheh V; Hajizadeh F; Atyabi F; Assali A; Mirzazadeh Tekie FS; Namdar A; Ghalamfarsa G; Sojoodi M; Jadidi-Niaragh F
    Pharm Res; 2020 Sep; 37(10):196. PubMed ID: 32944844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIF-1α/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells.
    Karpisheh V; Fakkari Afjadi J; Nabi Afjadi M; Haeri MS; Abdpoor Sough TS; Heydarzadeh Asl S; Edalati M; Atyabi F; Masjedi A; Hajizadeh F; Izadi S; Mirzazadeh Tekie FS; Hajiramezanali M; Sojoodi M; Jadidi-Niaragh F
    Int J Biol Macromol; 2021 Jan; 167():1006-1019. PubMed ID: 33227333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth.
    Budi HS; Izadi S; Timoshin A; Asl SH; Beyzai B; Ghaderpour A; Alian F; Eshaghi FS; Mousavi SM; Rafiee B; Nikkhoo A; Ahmadi A; Hassannia H; Ahmadi M; Sojoodi M; Jadidi-Niaragh F
    Nanomedicine; 2021 Jun; 34():102373. PubMed ID: 33667724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression.
    Salimifard S; Karoon Kiani F; Sadat Eshaghi F; Izadi S; Shahdadnejad K; Masjedi A; Heydari M; Ahmadi A; Hojjat-Farsangi M; Hassannia H; Mohammadi H; Boroumand-Noughabi S; Keramati MR; Jadidi-Niaragh F
    Life Sci; 2020 Nov; 260():118423. PubMed ID: 32941896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo.
    Salehi Khesht AM; Karpisheh V; Sahami Gilan P; Melnikova LA; Olegovna Zekiy A; Mohammadi M; Hojjat-Farsangi M; Majidi Zolbanin N; Mahmoodpoor A; Hassannia H; Aghebati-Maleki L; Jafari R; Jadidi-Niaragh F
    Int J Biol Macromol; 2021 Sep; 186():849-863. PubMed ID: 34245737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer.
    Zhang W; Xu W; Lan Y; He X; Liu K; Liang Y
    Int J Nanomedicine; 2019; 14():5287-5301. PubMed ID: 31406460
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-angiogenic effects of CD73-specific siRNA-loaded nanoparticles in breast cancer-bearing mice.
    Ghalamfarsa G; Rastegari A; Atyabi F; Hassannia H; Hojjat-Farsangi M; Ghanbari A; Anvari E; Mohammadi J; Azizi G; Masjedi A; Yousefi M; Yousefi B; Hadjati J; Jadidi-Niaragh F
    J Cell Physiol; 2018 Oct; 233(10):7165-7177. PubMed ID: 29741783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Codelivery of STAT3 siRNA and BV6 by carboxymethyl dextran trimethyl chitosan nanoparticles suppresses cancer cell progression.
    Nikkhoo A; Rostami N; Farhadi S; Esmaily M; Moghadaszadeh Ardebili S; Atyabi F; Baghaei M; Haghnavaz N; Yousefi M; Aliparasti MR; Ghalamfarsa G; Mohammadi H; Sojoodi M; Jadidi-Niaragh F
    Int J Pharm; 2020 May; 581():119236. PubMed ID: 32240809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells.
    Jafari R; Majidi Zolbanin N; Majidi J; Atyabi F; Yousefi M; Jadidi-Niaragh F; Aghebati-Maleki L; Shanehbandi D; Soltani Zangbar MS; Rafatpanah H
    Iran Biomed J; 2019 Jan; 23(1):21-33. PubMed ID: 30041514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression.
    Hajizadeh F; Moghadaszadeh Ardebili S; Baghi Moornani M; Masjedi A; Atyabi F; Kiani M; Namdar A; Karpisheh V; Izadi S; Baradaran B; Azizi G; Ghalamfarsa G; Sabz G; Yousefi M; Jadidi-Niaragh F
    Eur J Pharmacol; 2020 Sep; 882():173235. PubMed ID: 32574672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of p68 and STAT3 synergistically diminishes cancer progression.
    Hashemi V; Ahmadi A; Malakotikhah F; Chaleshtari MG; Baghi Moornani M; Masjedi A; Sojoodi M; Atyabi F; Nikkhoo A; Rostami N; Baradaran B; Azizi G; Yousefi B; Ghalamfarsa G; Jadidi-Niaragh F
    Life Sci; 2020 May; 249():117499. PubMed ID: 32142763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the therapeutic efficacy of codelivery of psiRNA-vascular endothelial growth factor and pIL-4 into chitosan nanoparticles in the breast tumor model.
    Şalva E; Turan SO; Kabasakal L; Alan S; Özkan N; Eren F; Akbuğa J
    J Pharm Sci; 2014 Mar; 103(3):785-95. PubMed ID: 24357345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant blockade of A2AR and CTLA-4 by siRNA-loaded polyethylene glycol-chitosan-alginate nanoparticles synergistically enhances antitumor T-cell responses.
    Ghasemi-Chaleshtari M; Kiaie SH; Irandoust M; Karami H; Nabi Afjadi M; Ghani S; Aghaei Vanda N; Ghaderi Sede MJ; Ahmadi A; Masjedi A; Hassannia H; Atyabi F; Hojjat-Farsangi M; Namdar A; Ghalamfarsa G; Jadidi-Niaragh F
    J Cell Physiol; 2020 Dec; 235(12):10068-10080. PubMed ID: 32488862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer.
    Luo K; Gao Y; Yin S; Yao Y; Yu H; Wang G; Li J
    Acta Biomater; 2021 Oct; 134():649-663. PubMed ID: 34289420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate receptor-targeted RNAi nanoparticles for silencing STAT3 in tumor-associated macrophages and tumor cells.
    Chen J; Dou Y; Tang Y; Zhang X
    Nanomedicine; 2020 Apr; 25():102173. PubMed ID: 32084593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin.
    Alshaer W; Alqudah DA; Wehaibi S; Abuarqoub D; Zihlif M; Hatmal MM; Awidi A
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.